Oramed Pharmaceuticals Inc. (ORMP) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 2M | 0 | 0 | 0 | 0 | 0 | 0 | 674K | 666K | 681K | 682K | 674K | 666K | 674K | 683K | 681K |
| Revenue Growth % | -100% | - | - | - | - | - | - | -100% | -100% | -100% | -100% | 0% | 0% | 1.04% | -0.15% | -1.03% | 0.15% | 0% | 0.29% | 0% |
| Cost of Goods Sold | 0 | 0 | 31K | 0 | 1.99M | 31K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | 99.35% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | -31K | 0 | 13K | -31K | 0 | 0 | 0 | 0 | 0 | 674K | 666K | 681K | 682K | 674K | 666K | 674K | 683K | 681K |
| Gross Margin % | - | - | - | - | 0.65% | - | - | - | - | - | - | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | -100% | 100% | - | - | - | - | - | -100% | -100% | -100% | -100% | 0% | 0% | 1.04% | -0.15% | -1.03% | 0.15% | 0% | 0.29% | 0% |
| Operating Expenses | 3.66M | 5.67M | 2.4M | 2.49M | 4.51M | 3.6M | 3.09M | 3.13M | 2.96M | 3.88M | 2.89M | 4.46M | 5.87M | 10.42M | 8.87M | 12.09M | 11.92M | 8.73M | 8.09M | 6.8M |
| OpEx % of Revenue | - | - | - | - | 225.65% | - | - | - | - | - | - | 662.46% | 881.98% | 1530.25% | 1300.73% | 1793.92% | 1789.49% | 1295.85% | 1184.92% | 998.38% |
| Selling, General & Admin | 2.06M | 3.68M | 1.27M | 1.46M | 2.31M | 2.13M | 847K | 1.69M | 1.78M | 2.11M | 1.94M | 2.64M | 1.45M | 3.14M | 3.52M | 2.91M | 6.08M | 2.32M | 2.25M | 1.3M |
| SG&A % of Revenue | - | - | - | - | 115.35% | - | - | - | - | - | - | 392.28% | 217.27% | 461.67% | 516.72% | 432.05% | 913.21% | 344.81% | 329.28% | 190.46% |
| Research & Development | 1.59M | 1.99M | 1.15M | 1.03M | 2.21M | 1.46M | 2.24M | 1.44M | 1.18M | 1.77M | 957K | 1.82M | 4.43M | 7.28M | 5.35M | 9.18M | 5.84M | 6.41M | 5.84M | 5.5M |
| R&D % of Revenue | - | - | - | - | 110.3% | - | - | - | - | - | - | 270.18% | 664.71% | 1068.58% | 784.02% | 1361.87% | 876.28% | 951.04% | 855.64% | 807.93% |
| Other Operating Expenses | 0 | 0 | -31K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 0 | -5.67M | -2.43M | -2.49M | -4.5M | -3.6M | -3.09M | -3.13M | -2.96M | -3.88M | -2.89M | -3.79M | -5.21M | -9.74M | -8.19M | -11.42M | -11.25M | -8.06M | -7.41M | -6.12M |
| Operating Margin % | - | - | - | - | -225% | - | - | - | - | - | - | -562.46% | -781.98% | -1430.25% | -1200.73% | -1693.92% | -1689.49% | -1195.85% | -1084.92% | -898.38% |
| Operating Income Growth % | 100% | -57.77% | 21.43% | 20.61% | -51.92% | 7.27% | -6.78% | 17.3% | 43.13% | 60.2% | 64.67% | 66.8% | 53.71% | -20.84% | -10.51% | -86.61% | -131.14% | -38.32% | -145.61% | -169.04% |
| EBITDA | 0 | -5.64M | -2.4M | -2.46M | -4.47M | -3.56M | -3.04M | -3.08M | -2.91M | -3.82M | -2.84M | -3.74M | -5.17M | -6.79M | -8.17M | -11.4M | -11.24M | -8.05M | -7.39M | -6.09M |
| EBITDA Margin % | - | - | - | - | -223.5% | - | - | - | - | - | - | -554.75% | -776.43% | -996.92% | -1198.53% | -1691.69% | -1687.84% | -1194.07% | -1082.14% | -894.27% |
| EBITDA Growth % | 100% | -58.31% | 21.11% | 20.19% | -53.82% | 6.8% | -6.97% | 17.6% | 43.8% | 43.67% | 65.27% | 67.21% | 54% | 15.64% | -10.59% | -87.22% | -132.25% | -38.16% | -145.14% | -168.16% |
| D&A (Non-Cash Add-back) | 0 | 30K | 31K | 30K | 30K | 31K | 52K | 54K | 56K | 53K | 54K | 52K | 37K | 2.95M | 15K | 15K | 11K | 12K | 19K | 28K |
| EBIT | 0 | 9.8M | 59.45M | 13.13M | -4.5M | -9.78M | -3.09M | 11.1M | 2.13M | 14.51M | 0 | -3.79M | -5.21M | -9.74M | -8.19M | -11.42M | -11.25M | 0 | -7.41M | -6.12M |
| Net Interest Income | 0 | 0 | 509K | 15.37M | -2.56M | -3.9M | -15.42M | 13.97M | 4.5M | 17.17M | -391K | 2.48M | 1.6M | 0 | -1.04M | 0 | 0 | -38K | 0 | -493K |
| Interest Income | 0 | 0 | 509K | 15.37M | 0 | -19.32M | 0 | 14.23M | 5.09M | 18.38M | 435K | 2.48M | 1.6M | 0 | 0 | 350K | 544K | 137K | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 2.56M | -15.42M | 15.42M | 261K | 592K | 1.21M | 826K | 0 | 0 | 0 | 1.04M | 350K | 544K | 175K | 0 | 493K |
| Other Income/Expense | 0 | 15.47M | 61.88M | 15.62M | -2.56M | -6.19M | -15.42M | 13.97M | 4.5M | 17.17M | -391K | 2.48M | 1.6M | 1M | 1.04M | 350K | 544K | -38K | 224K | 493K |
| Pretax Income | 49.44M | 9.8M | 59.45M | 13.13M | -7.06M | -9.78M | -18.51M | 10.84M | 1.53M | 13.3M | -3.28M | -1.31M | -3.61M | -8.74M | -7.15M | -11.07M | -10.71M | -8.1M | -7.19M | -5.63M |
| Pretax Margin % | - | - | - | - | -352.9% | - | - | - | - | - | - | -194.81% | -542.19% | -1282.82% | -1048.83% | -1641.99% | -1607.81% | -1201.48% | -1052.12% | -825.99% |
| Income Tax | 11.13M | -212K | 11.06M | -126K | 584K | 416K | 1.13M | 1.63M | 0 | 0 | 373K | -119K | -1.81M | -193K | 100K | -534K | -283K | -208K | -333K | -418K |
| Effective Tax Rate % | 22.51% | -2.16% | 18.61% | -0.96% | -8.27% | -4.25% | -6.12% | 15.08% | 0% | 0% | -11.36% | 9.06% | 50.21% | 2.21% | -1.4% | 4.83% | 2.64% | 2.57% | 4.63% | 7.43% |
| Net Income | 38.31M | 10.01M | 48.4M | 13.29M | -7.64M | -10.19M | -19.62M | 9.21M | 1.54M | 13.34M | -3.22M | -1.19M | -1.8M | -8.54M | -7.25M | -10.53M | -10.43M | -7.89M | -6.85M | -5.21M |
| Net Margin % | - | - | - | - | -382.1% | - | - | - | - | - | - | -177.15% | -269.97% | -1254.48% | -1063.49% | -1562.76% | -1565.32% | -1170.62% | -1003.37% | -764.61% |
| Net Income Growth % | 601.31% | 198.23% | 346.67% | 44.25% | -597.53% | -176.4% | -508.91% | 871.52% | 185.43% | 256.1% | 55.58% | 88.66% | 82.75% | -8.28% | -5.84% | -102.29% | -126.24% | -41.65% | -128.74% | -127.98% |
| Net Income (Continuing) | 38.31M | 10.01M | 48.39M | 13.26M | -7.64M | -10.2M | -19.64M | 9.2M | 1.53M | 13.3M | - | -1.19M | -1.8M | -8.54M | -7.25M | -10.53M | -10.43M | -7.89M | -6.85M | -5.21M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | -952K | -946K | -918K | -918K | -919K | -911K | -918K | -928K | -902K | -891K | -822K | -656K | -661K | -660K | -126K | 536K | 744K | 1.08M |
| EPS (Diluted) | 0.91 | 0.23 | 1.13 | 0.31 | -0.19 | -0.26 | -0.48 | 0.22 | 0.04 | 0.33 | -0.08 | -0.03 | -0.04 | -0.22 | -0.19 | -0.27 | -0.27 | -0.22 | -0.23 | -0.17 |
| EPS Growth % | 578.95% | 188.46% | 335.42% | 40.91% | -613.51% | -178.79% | -502.26% | 840.74% | 182.41% | 250% | 58.05% | 89% | 83.37% | 0% | 17.39% | -58.82% | -58.82% | 4.35% | -76.92% | -72.76% |
| EPS (Basic) | 0.94 | 0.23 | 1.16 | 0.32 | -0.19 | -0.26 | -0.48 | 0.22 | 0.04 | 0.33 | -0.08 | -0.03 | -0.04 | -0.22 | -0.19 | -0.27 | -0.27 | -0.22 | -0.23 | -0.17 |
| Diluted Shares Outstanding | 41.97M | 42.42M | 42.77M | 42.61M | 41.23M | 39.92M | 40.9M | 41.59M | 41.56M | 40.51M | 40.45M | 40.23M | 40.04M | 39M | 39.1M | 38.8M | 38.68M | 36.67M | 29.93M | 29.93M |
| Basic Shares Outstanding | 40.77M | 41.4M | 41.76M | 41.74M | 41.23M | 39.92M | 40.9M | 40.96M | 40.84M | 40.38M | 40.45M | 40.23M | 40.04M | 39M | 39.1M | 38.8M | 38.68M | 36.67M | 29.93M | 29.93M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |